Drug-induced fever: a pharmacovigilance analysis based on the FDA adverse event reporting system

Key Points

• This analysis aims to identify drugs and patient characteristics linked to drug-induced fever.
• Conducted a pharmacovigilance analysis using the FDA adverse event reporting system.
• Analyzed drug associations and patient demographics related to reported drug-induced fever cases.
• Evaluated onset patterns to determine early recognition trends.
• Identified specific drugs frequently associated with drug-induced fever.
• Revealed significant patient characteristics that correlate with onset of fever.
• Demonstrated patterns indicating the importance of early monitoring in clinical settings.